Psychedelic Stocks Hollister Bioscieinces Inc. (OTCMKTS:HSTRF) Announce Acquisition of Alphamind Brands And Venom Extracts By Larry Zweig April 07, 2021 Hollister Bioscieinces Inc. (OTCMKTS:HSTRF) has announced the signing of a letter of intent dated March 9, 2020, for Alphamind Brands' acquisition. Alphamind is a developer of legal mushroom-based natural health products, which ca...
Psychedelic Stocks COMPASS Pathways Plc (NASDAQ:CMPS) Expands its Discovery Center Through Partnerships and Establishes Center of Excellence In Baltimore, Maryland By Larry Zweig April 07, 2021 COMPASS Pathways Plc (NASDAQ:CMPS) has announced an expansion of its Discovery Centre through a partnership with leading labs at Medical College of Wisconsin (MCW) and UC San Diego, School of Medicine. Discovery center to develop...
Psychedelic Stocks Focusing On Psychedelics Revival And Its Impact On Neuroscience By Larry Zweig April 07, 2021 A brain-computer interface (BCI) pioneer known as Kernel has disclosed details about its plan to collaborate with Cybin, which happens to be a biotech company based in Toronto. The new partnership will see the two parties focus on...
Psychedelic Stocks Psychedelic Mushroom Therapies Might Be Booming, But Little Has Been Done, To protect People By Larry Zweig April 07, 2021 Currently, there is a psychedelic mushrooms boom with new funds such as Atai raising millions to invest in the sector. Several new companies working on psychedelics are listing, and one such company is Compass Pathways, which was ...
Psychedelic Stocks With Oregon Legalizing Psilocybin Therapy, Will The Federal Government Finally Move TO Decriminalize Psychedelics? By Larry Zweig March 30, 2021 Although psychedelic reform is not a top priority for President Joe Biden's administration, advocates are optimistic that with the new administration, there might some new policy changes that will decriminalize MDMA, psilocybin, a...
Trends & Articles Revive Therapeutics Ltd. (OTCMKTS:RVVTF) Offers Update On Its Bucillamine Trial In COVID-19 Treatment By Larry Zweig March 22, 2021 Revive Therapeutics Ltd. (OTCMKTS:RVVTF) has announced an update on its US FDA third phase clinical study evaluating Bucillamine’s safety and efficacy in patients having mild-to moderated coronavirus. Revive expanding its Phase...
Psychedelic Stocks Champignon Brands Inc.’s (OTCMKTS:SHRMF) Open Third CRTCE Clinic And Announce Publication In The Lancet By Larry Zweig March 19, 2021 Champignon Brands Inc.’s (OTCMKTS:SHRMF) CEO and Chairman Roger McIntyre has announced a Canadian Rapid Treatment Centre of Excellence clinic in Ottawa, Ontario. The CRTCE clinic is the third clinic the company is opening, joini...
Psychedelic Stocks MindMed (OTCMKTS:MMEDF) Announce acquisition of HealthMode and Partnership With MindShift On Psychedelic Substances By Larry Zweig March 18, 2021 MindMed (OTCMKTS:MMEDF) has announced plans to acquire HealthMode to help it develop a mental health digital platform for psychedelic medicines. HealthMode is a therapeutics and digital medicine startup employing AI-enabled digi...